Fibrosis, a common pathway to organ failure: Angiotensin II and tissue repair

Seminars in Nephrology

Volumn 17, Issue 5, 1997, Pages 467-491

  Weber, Karl T ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

CELL TRANSFORMATION; DRUG EFFECT; FIBROBLAST; FIBROSIS; HORMONE ACTION; HUMAN; INFLAMMATORY CELL; MULTIPLE ORGAN FAILURE; MYOFIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW;

ANGIOTENSIN II; ANIMALS; CULTURE TECHNIQUES; FIBROSIS; HUMANS; KIDNEY; LIVER; LUNG; MULTIPLE ORGAN FAILURE; MYOCARDIUM; WOUND HEALING;

EID: 0030930322     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (284)

1. Weber KT: Exploring common ground [editorial]. Hosp Pract 15:29:11-12, 1995
2. Tan LB, Jalil JE, Pick R, et al: Cardiac myocyte necrosis induced by angiotensin II. Circ Res 69:1185-1195, 1991
3. Benjamin IJ, Jalil JE, Tan LB, et al: Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 65:657-670, 1989
4. Ratajska A, Campbell SE, Sun Y, Weber KT: Angiotenin II associated cardiac myocyte necrosis: role of adrenal catecholamines. Cardiovasc Res 28:684-690, 1994
5. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT: Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 28:1423-1432, 1994
6. Jugdutt BI, Amy RWM: Healing after myocardial infarction in the dog: Changes in infarct hydroxyproline and topography. J Am Coll Cardiol 7:91-102, 1986
7. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849-1865, 1991
8. Brilla CG, Pick R, Tan LB, et al: Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 67:1355-1364, 1990
9. Sun Y, Ratajska A, Zhou G, Weber KT: Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med 122:395-403, 1993
10. Goldblatt H: Experimental hypertension induced by renal ischemia (Harvey Lecture). Bull NY Acad Med 14:523-553, 1938
11. Hall CE, Hall O: Hypertension and hypersalimentation. I. Aldosterone hypertension. Lab Invest 14:285-294, 1965
12. Reddy HK, Campbell SE, Janicki JS, et al: Coronary microvascular fluid flux and permeability: Influence of angiotensin II, aldosterone and acute arterial hypertension. J Lab Clin Med 121:510-521, 1993
13. Reddy HK, Sigusch H, Zhou G, et al: Coronary vascular hyperpermeability and angiotensin II. J Lab Clin Med 126:307-315, 1995
14. Ratajska A, Campbell SE, Cleutjens JPM, Weber KT: Angiotensin II and structural remodeling of coronary vessels in rats. J Lab Clin Med 124:408-415, 1994
15. Sigusch HH, Ou R, Katwa LC, et al: Angiotensin-IIinduced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products. Cardiovasc Res 30:291-298, 1995
16. González-Avila G, Vadillo-Ortega F, Perez-Tamayo R: Experimental diffuse interstitial renal fibrosis. A biochemical approach. Lab Invest 59:245-252, 1988
17. Bellamy COC, Malcomson RDG, Harrison DJ, Wyllie AH: Cell death in health and disease: The biology and regulation of apoptosis. Semin Cancer Biol 6:3-16, 1995
18. Weber KT: Cardiac interstitium in health and disease: The fibrillar collagen network. J Am Coll Cardiol 13:16371652, 1989
19. Weber KT: Stroma and the search for common ground. Cardiovasc Res 29:330-335, 1995
20. Müller GA, Schettler V, Müller CA, Strutz F: Prevention of progression of renal fibrosis: How far are we? Kidney Int 49:575-82, 1996 (Suppl 54)
21. Eddy AA: Interstitial macrophages as mediators of renal fibrosis. Exp Nephrol 3:76-79, 1995
22. Adler KB, Low RB, Leslie KO, et al: Biology of dis-ease. Contractile cells in normal and fibrotic lung. Lab Invest 60:473-485, 1989
23. Dunnill MS: Pulmonary fibrosis. Histopathology 16:321-329, 1990
24. Friedman SL: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328:1828-1835, 1993
25. Pérez-Tamayo R: Collagen resorption in carrageenin granulomas. I. Collagenolytic activity in in vitro expiants. Lab Invest 22:137-141, 1970
26. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
27. Strutz F, Müller GA: On the progression of chronic renal disease. Nephron 69:371-379, 1995
28. Weber KT, Sun Y, Campbell SE, et al: Chronic mineralocorticoid excess and cardiovascular remodeling. Steroids 60:125-132, 1995
29. Beltrami CA, Finato N, Rocco M, et al: Structural basis of end-stage failure in ischémie cardiomyopathy in humans. Circulation 89:151-163, 1994
30. Cotran RS, Kumar V, Robbins SL: Robbins' Pathologic Basis of Disease, 4th ed. Philadelphia, PA, W B Saunders, 1989, p 614
31. Weber KT, Brilla CG, Janicki JS: Myocardial fibrosis: Functional significance and regulatory factors. Cardiovasc Res 27:341-348, 1993
32. Pahor M, Bernabei R, Sgadari A, et al: Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 18:148-157, 1991
33. Sharma AK, Mauer SM, Kim Y, Michael AF: Interstitial fibrosis in obstructive nephropathy. Kidney Int 44:774788, 1993
34. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
35. McAnulty RJ, Laurent GJ: Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol 3:96-107, 1995
36. Madri JA, Furthmayr H: Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Hum Pathol 11:353-366, 1980
37. Davidsohn C: Ueber muskulare lungencirrhose. Berl Klin Wochnschr 44:33-35, 1907
38. von Stössel E: uber muskulare cirrhose der lunge. Beitr Klin Tuberk 90:432-442, 1937
39. Vane JR, Mitchell JA, Appleton I, et al: Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sei U S A 91:2046-2050, 1994
40. Riches DWH: Macrophage involvement in wound repair, remodeling, and fibrosis, in Clark RAF (ed): The Molecular and Cellular Biology of Wound Repair, 2nd ed. New York, NY, Plenum Press, 1996, pp 95-141
41. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330, 1995
42. Reimer KA, Jennings RB: Myocardial ischemia, hypoxia, and infarction, in Fozzard HA, Haber E, Jennings RB, et al (eds): The Heart and Cardiovascular System. New York, NY, Raven Press, 1986, pp 1133-201
43. Todd GL, Baroldi G, Pieper GM, et al: Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. J Mol Cell Cardiol 17:317-338, 1985
44. Todd GL, Baroldi G, Pieper GM, et al: Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced contraction band lesions correlated with ECO, hemodynamic and biochemical changes. J Mol Cell Cardiol 17:647-656, 1985
45. Judd JT, Wexler BC: Myocardial connective tissue metabolism in response to injury. Histological and chemical studies of mucopolysaccharide and collagen in rat hearts after isoproterenol-induced infarction. Circ Res 25:201-214, 1969
46. Nicoletti A, Mandet C, Challah M, et al: Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats. Cardiovasc Res 31:585-595, 1996
47. Campbell SE, Janicki JS, Weber KT: Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 27:1545-1560, 1995
48. Freed MS, Spaethe SM, Lefkowith JB, et al: Essential fatty acid deficiency inhibits early but not late leukocyte infiltration in rabbit myocardial infarcts. Prostaglandins 38:33-44, 1989
49. Lefkowith JB, Schreiner GF: Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. J Clin Invest 80:947-956, 1987
50. Brown EJ, Kloner RA, Schoen FJ, et al: Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol 51:877-883, 1983
51. Vivaldi MT, Eyre DR, Kloner RA, Schoen FJ: Effects of methylprednisone on collagen biosynthesis in healing acute myocardial infarction. Am J Cardiol 60:424-425, 1987
52. Shizukuda Y, Miura T, Ishimoto R, et al: Effect of prednisone on myocardial infarct healing: Characteristics and comparison with indomethacin. Can J Cardiol 7:447-454, 1991
53. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287, 1994
54. Diamond JR, Pesek I, Ruggieri S, Karnovsky MJ: Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol 257:F798-807, 1989
55. Harris KPG, Lefkowith JB, Klahr S, Schreiner GF: Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin. J Clin Invest 86:1115-1123, 1986
56. Schreiner GF, Rovin B, Lefkowith JB: The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism. J Immunol 143:31923199, 1989
57. Rovin BH, Lefkowith JB, Schreiner GF: Mechanisms underlying the anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. Inhibited release of a monocyte chemoattractant by glomeruli. J Immunol 145:1238-1245, 1990
58. Spaethe SM, Freed MS, De Schryver-Kecskemeti K, et al: Essential fatty acid deficiency reduces the inflammatory cell invasion in rabbit hydronephrosis resulting in suppression of the exaggerated eicosanoid production. J Pharmacol Exp Ther 245:1088-1094, 1988
59. Leibovich SJ, Ross R: A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol 84:501-514, 1976
60. Diamond JR, Kees-Folts D, Ding G, et al: Macrophages, monocyte chemoattractant peptide-1 and TGF-β1 in experimental hydronephrosis. Am J Physiol 266:F926-933, 1994
61. Bitterman PB, Adelberg S, Crystal RG: Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest 72:1801-1813, 1983
62. 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 92:632-637, 1993
63. Phan SH, Kunkel SL: Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 18:29-43, 1992
64. Denholm EM, Rollins SM: Expression and secretion of transforming growth factor-β by bleomycin-stimulated rat alveolar macrophages. Am J Physiol 264:L36-42, 1993
65. Khalil N, Whitman C, Zuo L, Danielpour D, Greenberg A: Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 92:1812-1818, 1993
66. Giri SN, Hyde DM, Hollinger MA: Effect of antibody to transforming growth factor βon bleomycin induced accumulation of lung collagen in mice. Thorax 48:959-966, 1993
67. Johnson SJ, Mines JE, Burt AD: Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol 166:351358, 1992
68. Zerbe O, Gressner AM: Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp Mol Pathol 49:87-101, 1988
69. Friedman SL: Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 10:2029, 1990
70. Sappino AP, Schüren W, Gabbiani G: Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144-161, 1990
71. McCulloch CAO, Bordin S: Role of fibroblast subpopulations in periodontal physiology and pathology. J Periodont Res 26:144-154, 1991
72. Schmitt-Graff A, Desmouliere A, Gabbiani G: Heterogeneity of myofibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchows Archiv 425:3-24, 1994
73. Komuro T: Re-evaluation of fibroblasts and fibroblastlike cells. Anat Embryol 182:103-112, 1990
74. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-β 1 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103-111, 1993
75. Shi Y, Pieniek M, Fard A, O'brien JE Jr, et al: Adventitial remodeling after coronary arterial injury. Circulation 93:340-348, 1996
76. Shi Y, O'Brien JE Jr, Fard A, Zalewski A: Transforming growth factor-β 1 expression and myofibroblast for-mation during arterial repair. Arterioscler Thromb Vase Biol 16:1298-1305, 1996
77. Bachern MG, Meyer D, Melchior R, et al: Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 89:19-27, 1992
78. Thompson NL, Bazobeny F, Speir EH, et al: Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1:91-99, 1988
79. Casscells W, Bazobeny F, Speir E, et al: Transforming growth factor-β 1 in normal heart and in myocardial infarction. Ann NY Acad Sei 593:148-160, 1990
80. Zhang G, Moorhead PJ, el Nahas AM: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 3:308-318, 1995
81. Vracko R, Thorning D: Contractile cells in rat myocardial scar tissue. Lab Invest 65:214-227, 1991
82. Leslie KO, Taatjes DJ, Schwarz J, et al: Cardiac myofibroblasts express alpha smooth muscle actin during right ventricular pressure overload in the rabbit. Am J Pathol 139:207-216, 1991
83. Bishop JE, Rhodes S, Laurent GJ, et al: Increased collagen synthesis and decreased collagen degradation in right ventricular hypertrophy induced by pressure overload. Cardiovasc Res 28:1581-1585, 1994
84. Majno G: The story of the myofibroblasts. Am J Surg Pathol 3:535-542, 1979
85. Gabbiani G, Hirschel BJ, Ryan GB, et al: Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 135:719-734, 1972
86. Desmouliere A, Gabbiani G: The role of the myofibroblast in wound healing and fibrocontractive diseases, in Clark RAF (ed) The Molecular and Cellular Biology of Wound Repair, 2nd ed. New York, NY, Plenum Press, 1996, pp 391-423
87. Singer II, Kawka DW, Kazazis DM, Clark RAF: In vivo co-distribution of fibronectin and actin fibers in granulation tissue: Immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. I Cell Biol 98:2091-2106, 1984
88. Bishop J, Greenbaum J, Gibson D, et al: Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol 22:1157-1165, 1990
89. Mukherjee D, Sen S: Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res 67:1474-1480, 1990
90. Weber KT, Janicki JS, Shroff SG, et al: Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 62:757-765, 1988
91. Cleutjens JPM, Verluyten MJA, Smits JFM, Daemen MJAP: Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 147:325-338, 1995
92. Kapanci Y, Assimacopoulos A, Irle C, et al: "Contractile interstitial cells" in pulmonary alveolar septa: A possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol 60:375392, 1974
93. Appleton I, Tomlinson A, Chander CL, Willoughby DA: Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologie and immunohistochemical study. Lab Invest 67:703-710, 1992
94. Darby I, Skalli O, Gabbiani G: a-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63:21-29, 1990
95. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56-66, 1995
96. Willems IEMG, Havenith MG, De Mey JGR, Daemen MJAP: The a-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 145:868-875, 1994
97. Nagle RB, Bulger RE, Cutler RE, et al: Unilateral obstructive nephropathy in the rabbit: I. Early morphologic, physiologic, and histochemical changes. Lab Invest 28:456467, 1973
98. Johnson RJ, Floege J, Yoshimura A, et al: The activated mesangial cell: A glomerular "myofibroblast"? J Am Soc Nephrol 2:5190-197, 1992
99. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49:1110-1119, 1996
100. Ishidoya S, Morrissey J, McCracken R, et al: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995
101. Nagle RB, Johnson ME, Jervis HR: Proliferation of renal interstitial cells following injury induced by ureteral obstruction. Lab Invest 35:18-22, 1976
102. Goumenos DS, Brown CB, Shortland J, El Nahas AM: Myofibroblasts, predictors of progression of mesangial IgA nephropathy. Nephrol Dial Transplant 9:1418-1425, 1994
103. Sharma AK, Mauer SM, Kim Y, Michael AF: Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. J Lab Clin Med 125:754-761, 1995
104. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
105. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 5:201-210, 1994
106. MacPherson BR, Leslie KO, Lizaso KV, Schwarz JE: Contractile cells of the kidney in primary glomerular disorders: An immunohistochemical study using an antialpha-smooth muscle actin monoclonal antibody. Hum Pathol 24:710-716, 1993
107. Vyalov SL, Gabbiani G, Kapanci Y: Rat alveolar myofibroblasts acquire a-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 143:1754-1765, 1991
108. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 145:114-125, 1994
109. Mitchell J, Woodcock-Mitchell J, Reynolds S, et al: a-smooth muscle actin in parenchyma! cells of bleomycininjured rat lung. Lab Invest 60:643-650, 1989
110. Kühn C, McDonald JA: The roles of the myofi-broblast in idiopathic pulmonary fibrosis. Am J Pathol 138:1257-1265, 1991
111. Pierce RA, Glaug MR, Freco RS, et al: Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats. J Biol Chem 262:1652-1658, 1987
112. Milani S, Herbst H, Schuppan D, et al: In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in non-parenchymal liver cells. Hepatology 10:84-92, 1989
113. Ballardini G, Fallani M, Biagini G, et al: Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol Incl Mol Pathol 56:45-49,1988
114. Geerts A, Greenwel P, Cunningham M, et al: Identification of connective tissue gene transcripts in freshly isolated parenchyma!, endothelial, Kupffer and fat-storing cells by Northern hybridization analysis. J Hepatol 19:148-158, 1993
115. Bachern MG, Sell K-M, Melchior R, et al: Tumor necrosis factor alpha (TNFα) and transforming growth factor β1 (TGFβ1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol 63:123-130, 1993
116. Sommer P, Gleysal C, Raccurt M, et al: Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis. Lab Invest 69:460-470, 1993
117. Floege J, Gröne H-J: Progression of renal failure: What is the role of cytokines? Nephrol Dial Transplant 10:1575-1586, 1995
118. Lawrence WT, Diegelmann RF: Growth factors in wound healing. Clin Dermatol 12:157-169, 1994
119. Omura T, Kim S, Takeuchi K, et al: Transforming growth factor βl and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: Effects of inhibition of the renin-angiotensin system. Cardiovasc Res 28:1835-1842, 1994
120. Chua CC, Chua BHL, Zhao ZY, et al: Effect of growth factors on collagen metabolism in cultured human heart fibroblasts. Connect Tissue Res 26:271-281, 1991
121. Sadoshima J, Izumo S: Molecular characterization of angiotensin Il-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT, receptor subtype. Circ Res 73:413-423, 1993
122. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ: Angiotensin II stimulates the autocrine production of transforming growth factor-β! in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27:2347-2357, 1995
123. Everett AD, Tufro-McReddie A, Fisher A, Gomez RA: Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-β 1 expression. Hypertension 23:587-592, 1994
124. Hinglais N, Heudes D, Nicoletti A, et al: Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest 70:286-294, 1994
125. Pimentel JL Jr, Sundell CL, Wang S, et al: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48:1233-1246, 1995
126. Border WA, Noble NA, Yamamoto T, et al: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
127. Pimentel JL Jr, Martinez-Maldonado M, Wilcox JN, et al: Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 44:390-400, 1993
128. Jones CL, Buch S, Post M, et al: Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 141:1381-1396, 1992
129. Hoyt DG, Lazo JS: Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 246:765-771, 1988
130. Broekelmann TJ, Limper AH, Colby TV, et al: Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sei U S A 88:6642-6646, 1991
131. Sekita S, Katagiri T, Sasai Y, Takeda K: Studies on collagen in the experimental myocardial infarction. Jpn Cire J 49:171-178, 1985
132. Cleutjens JPM, Kandala JC, Guarda E, et al: Régulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281-1292, 1995
133. Knowlton AA, Connelly CM, Romo GM, et al: Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J Clin Invest 89:1060-1068, 1992
134. Sun Y, Weber KT: Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28:851-858, 1996
135. Hanatani A, Yoshiyama M, Kim S, et al: Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 27:1905-1914, 1995
136. Whittaker P: Unravelling the mysteries of collagen and cicatrix after myocardial infarction. Cardiovasc Res 31:19-27, 1996
137. McCormick RJ, Musch TI, Bergman BC, Thomas DP: Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Am J Physiol 266:H354-359, 1994
138. Pelouch V, Dixon IMC, Sethi R, Dhalla NS: Alteration of collagenous protein profile in congestive heart failure secondary to myocardial infarction. Mol Cell Biochem 129:121-131, 1993
139. van Krimpen C, Smits JFM, Cleutjens JPM, et al: DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat heart: Effects of captopril. J Mol Cell Cardiol 23:1245-1253, 1991
140. Smits JFM, van Krimpen C, Schoemaker RG, et al: Angiotensin II receptor blockade after myocardial infarction in rats: Effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 20:772-778, 1992
141. Litwin SE, Litwin CM, Raya TE, et al: Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition. Circulation 83:1028-1037, 1991
142. Volders PGA, Willems IEMG, Cleutjens JPM, et al: Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 25:1317-1323, 1993
143. Downer G, Phan SH, Wiggins RC: Analysis of renal fibrosis in a rabbit model of crescentic nephritis. J Clin Invest 82:998-1006, 1988
144. Merritt SE, Killen PD, Phan SH, Wiggins RC: Analysis ofal (I) procollagen δ1 (IV) collagen, and β-actin mRNA in glomerulus and cortex of rabbits with experimental antiglomerular basement membrane disease. Evidence for early extraglomerular collagen biosynthesis. Lab Invest 63:762769, 1990
145. Wiggins R, Goyal M, Merritt S, Killen PD: Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrand antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab Invest 68:557-565, 1993
146. Laurent GJ, McAnulty RJ: Protein metabolism during bleomycin-induced pulmonary fibrosis in rabbits. In vivo evidence for collagen accumulation because of increased synthesis and decreased degradation of the newly synthesized collagen. Am Rev Respir Dis 128:82-88, 1983
147. Arden MG, Adamson YR: Collagen synthesis and degradation during the development of asbestos-induced pulmonary fibrosis. Exp Lung Res 18:9-20, 1992
148. Kelley J, Chrin L, Shull S, et al: Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injury. Biochem Biophys Res Commun 131:836-843, 1985
149. Raghow R, Lurie S, Seyer JM, Kang AH: Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest 76:1733-1739, 1985
150. Ala-Kokko L, Pihlajaniemi T, Myers JC, et al: Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J 244:7579, 1987
151. Arthur MJP: Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 190:825-833, 1994
152. Johnson RJ, Alpers CE, Yoshimura A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
153. Sun Y, Weber KT: Angiotensin II and aldosterone receptor binding in rat heart and kidney: Response to chronic angiotensin II or aldosterone administration. J Lab Clin Med 122:404-411, 1993
154. Sun Y, Ratajska A, Weber KT: Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J Lab Clin Med 126:95-101, 1995
155. Sun Y, Ratajska A, Weber KT: Bradykinin receptor and tissue ACE binding in myocardial fibrosis: Response to chronic angiotensin II or aldosterone administration in rats. J Mol Cell Cardiol 27:813-822, 1995
156. Sun Y, Diaz-Arias AA, Weber KT: Angiotensin-converting enzyme, bradykinin and angiotensin II receptor binding in rat skin, tendon and heart valves: An in vitro quantitative autoradiographic study. J Lab Clin Med 123:372-377, 1994
157. Allen AM, Yamada H, Mendelsohn FAO: In vitro autoradiographic localization of binding to angiotensin receptors in the rat heart. Int J Cardiol 28:25-33, 1990
158. Yamada H, Fabris B, Allen AM, et al: Localization of angiotensin converting enzyme in rat heart. Circ Res 68:141-149, 1991
159. Pinto JE, Viglione P, Saavedra JM: Autoradiographic localization and quantification of rat heart angiotensin converting enzyme. Am J Hypertens 4:321-326, 1991
160. Danilov SM, Faerman AI, Printseva OY, et al: Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies. Histochemistry 87:487-490, 1987
161. Katwa LC, Ratajska A, Cleutjens JPM, et al: Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res 29:57-64, 1995
162. Sun Y, Weber KT: Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res 28:1623-1628, 1994
163. Filip DA, Radu A, Simionescu M: Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 59:310-320, 1986
164. Sims DE: The pericyte-a review. Tissue Cell 18:153174,1986
165. Hokimoto S, Yasue H, Fujimoto K, et al: Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction. Cardiovasc Res 29:664-669, 1995
166. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ: Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 66:22D30D; discussion 30D-32D, 1990
167. Yamagishi H, Kim S, Nishikimi T, et al: Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 25:1369-1380, 1993
168. Michel J-B, Lattion A-L, Salzmann J-L, et ai: Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 62:641-650, 1988
169. Pinto YM, de Smet BG, van Gilst WH, et al: Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: Relation to ventricular function and morphology. Cardiovasc Res 27:19331938, 1993
170. Hodsman GP, Kohzuki M, Howes LG, et al: Neurohumoral responses to chronic myocardial infarction in rats. Circulation 78:376-381, 1988
171. Falkenhahn M, Franke F, Bohle RM, et al: Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 25:219-226, 1995
172. Lefroy DC, Wharton J, Crake T, et al: Régional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol 28:429-440, 1996
173. Sechi LA, Griffin CA, Grady EF, et al: Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 71:1482-1489, 1992
174. Regitz-Zagrosek V, Friedel N, Heymann A, et al: Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91:1461-1471, 1995
175. Sun Y, Weber KT: Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res 31:518-525, 1996
176. Nio Y, Matsubara H, Murasawa S, et al: Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95:46-54, 1995
177. Makino N, Hata T, Sugano M, et al: Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type I receptor in rats. J Mol Cell Cardiol 28:507-517, 1996
178. Kimura B, Sumners C, Phillips MI: Changes in skin angiotensin II receptors in rats during wound healing. Biochem Biophys Res Commun 187:1083-1090, 1992
179. Phillips MI, Kimura B, Gyurko R: Angiotensin receptor stimulation of transforming growth factor-β in rat skin and wound healing, in Saavedra JM, Pieter BMWM (eds): Angiotensin Receptors. New York, NY, Plenum Press, 1994, pp 377-396
180. Viswanathan M, Saavedra JM: Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides 13:783-786, 1992
181. Ou R, Sun Y, Ganjam VK, Weber KT: In situ production of angiotensin II by fibrosed rat pericardium. J Mol Cell Cardiol 28:1319-1327, 1996
182. Sun Y, Ramires FJA, Weber KT: Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997 (in press)
183. Schunkert H, Ingelfinger JR, Hirsch AT, et al: Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 72:312-318, 1993
184. Campbell DJ, Habener JF: Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: Quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 121:1616-1626, 1987
185. Cassis LA, Lynch KR, Peach MJ: Localization of angiotensinogen messenger RNA in rat aorta. Circ Res 62:1259-1262, 1988
186. Sawa H, Tokuchi F, Mochizuki N, et al: Expression of the angiotensinogen
187. Dostal DE, Rothblum KN, Chemin MI, et al: Intracardiac detection of angiotensinogen and renin: A localized renin-angiotensin system in neonatal rat heart. Am J Physiol 263:C838-850, 1992
188. Dostal DE, Rothblum KN, Conrad KM, et al: Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol 263:C851-863, 1992
189. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH: Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 89:458-470, 1994
190. Danser AHJ, Koning MMG, Admiraal PJJ, et al: Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol 263:H429-437, 1992
191. Danser AHJ, Koning MMG, Admiraal PJJ, et al: Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol 263:H418-428, 1992
192. Danser AHJ, van Katz JP, Admiraal PJJ, et al: Cardiac renin and angiotensins: Uptake from plasma versus in situ synthesis. Hypertension 24:37-48, 1994
193. Campbell DJ, Kladis A, Duncan AM: Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 22:513-522, 1993
194. Klickstein LB, Kaempfer CE, Wintroub BU: The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G. J Biol Chem 257:15042-15046, 1982
195. Wintroub BU, Klickstein LB, Dzau VJ, et al: Granulocyte-angiotensin system. Identification of angiotensinogen as thé plasma protein substrate of leukocyte cathepsin G. Biochemistry 23:227-232, 1984
196. Katwa LC, Campbell SE, Tyagi SC, et al: Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997 (In press)
197. Katwa LC, Tyagi SC, Campbell SE, et al: Valvular interstitial cells express angiotensinogen, cathepsin D, and generate angiotensin peptides. Int J Biochem Cell Biol 28:807-821, 1996
198. Passier RCJJ, Smits JFM, Verluyten MJA, et al: Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 269:H 1268-1276, 1995
199. Iwai N, Inagami T, Ohmichi N, Kinoshita M: Renin is expressed in rat macrophage/monocyte cells. Hypertension 27:399-403, 1996
200. Zhang X, Dostal DE, Reiss K, et al: Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. Am J Physiol 269:H1791-1802, 1995
201. Weber KT, Sun Y, Katwa LC, Cleutjens JPM: Connective tissue: A metabolic entity? J Mol Cell Cardiol 27:107-120, 1995
202. Alien RKA, Chai SY, Dunbar MS, Mendelsohn FAO: In vitro autoradiographic localization of angiotensinconverting enzyme in sarcoid lymph nodes. Chest 90:315-320, 1986
203. Sun Y, Weber KT: Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med 127:94-101, 1996
204. Silverstein E, Pertschuk LP, Friedland J: Immunofluorescent localization of angiotensin converting enzyme in epitheloid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sei U S A 76:6646-6648, 1979
205. Thomas DW, Hoffman MD: Identification of macrophage receptors for angiotensin: A potential role in antigen uptake for T lymphocyte responses? J Immunol 132:28072812, 1984
206. Reilly CF, Tewksbury DA, Schlechter NM, Travis J: Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem 15:8619-8622, 1982
207. Kara A, Fukuyama K, Epstein WL: Angiotensin-converting enzyme and other enzymes in livers of mice with experimental schistosomiasis. Exp Mol Pathol 35:199-210, 1981
208. Weinstock JV, Boros DL, Gee JB: Enhanced granuloma angiotensin I converting enzyme activity associated with modulation in murine schistosomiasis. Gastroenterology 81:48-53, 1981
209. Weinstock JV, Blum AM: Isolated liver granulomas of murine Schistosoma mansoni contain components of the angiotensin system. J Immunol 131:2529-2532, 1983
210. Weinstock JV, Blum AM: Granuloma macrophages in murine Schistosomiasis mansoni generate components of the angiotensin system. Cell Immunol 89:39-45, 1984
211. Weinstock JV, Kassab JT: Functional angiotensin II receptors on macrophages from isolated liver granulomas of murine Schistosoma mansoni. J Immunol 132:2598-2602, 1984
212. Weinstock JV, Blum AM: Synthesis of angiotensins by cultured granuloma macrophages in murine schistosomiasis mansoni. Cell Immunol 107:273-280, 1987
213. Boloukhere M, Baldo-Correa E, Borojevic R: Experimental schistosomiasis mansoni: Characterization of connective tissue cells in hepatic periovular granulomas. J Submicrosc Cytol Pathol 25:505-517, 1993
214. Veale D, Yanni G, Bresnihan B, FitzGerald O: Production of angiotensin converting enzyme by rheumatoid synovial membrane. Ann Rheum Dis 51:476-480, 1992
215. Walsh DA, Suziki T, Knock GA, et al: AT| receptor characteristics of angiotensin analogue binding in human synovium. Br J Pharmacol 112:435-442, 1994
216. Martin MFR, Surrall KE, McKenna F, et al: Captopril: A new treatment for rheumatoid arthritis? Lancet 1(8390): 1325-1328, 1984
217. Keeley FW, Elmoselhi A, Leenen FHH: Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol 262:H1013-1021, 1992
218. Albaladejo P, Bouaziz H, Duriez M, et al: Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 23:74-82, 1994
219. Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE: Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation 91:802-812, 1995
220. Jugdutt BI, Schwarz-Michorowski BL, Khan MI: Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol 19:713-721, 1992
221. Jugdutt BI: Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol 25:1718-1725, 1995
222. Hashimoto K, Hirose M, Furukawa K, et al: Changes in hemodynamics and bradykinin concentration in coronary sinus blood in experimental coronary artery occlusion. Jpn Heart J 18:679-689, 1977
223. Needleman P, Marshall OR, Sobel BE: Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin. Circ Res 37:802-808, 1975
224. Noda K, Sasaguri M, Ideishi M, et al: Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 27:334-340, 1993
225. Frimm C de C, Sun Y, Weber KT: Wound healing following myocardial infarction in the rat: Role for bradykinin and prostaglandins. J Mol Cell Cardiol 28:1279-1285, 1996
226. Frimm C de C, Sun Y, Weber KT: Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. J Lab Clin Med 129:439-446, 1997
227. Makino N, Matsui H, Masutomo K, et al: Effect of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy. Mol Cell Biochem 119:23-28, 1993
228. Bélichard P, Savard P, Cardinal R, et al: Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol 23:505-513, 1994
229. Schieffer B, Wirger A, Meybrunn M, et al: Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89:2273-2282, 1994
230. Dixon IMC, Ju H, Jassal DS, Peterson DJ: Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction. Mol Cell Biochem 165:3145, 1996
231. Farivar RS, Crawford DC, Chobanian AV, Brecher P: Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart. Hypertension 25(part2):809-813, 1995
232. Shi Y, O'brien JE Jr, Fard A, et al: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94:1655-1664, 1996
233. Rakugi H, Kim D-K, Krieger JE, et al: Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 93:339346, 1994
234. Powell JS, Clozel JP, Muller RK, et al: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-188, 1989
235. Prescott MF, Webb RL, Reidy MA: Angiotensinconverting enzyme inhibitor versus angiotensin II, AT, receptor antagonist. Effects on smoothy muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 139:1291-1296, 1991
236. Osterrieder W, Müller RKM, Powell JS, et al: Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 18:1160-64, 1991 (Suppl 2)
237. Kim S, Kawamura M, Wanibuchi H, et al: Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation 92:88-95, 1995
238. Majesky MW, Lindner V, Twardzik DR, et al: Production of transforming growth factor β, during repair of arterial injury. J Clin Invest 88:904-910, 1991
239. Wolf YG, Rasmussen LM, Ruoslahti E: Antibodies against transforming growth factor-β 1 suppress intimai hyperplasia in a rat model. J Clin Invest 93:1172-1178, 1994
240. Brilla CG, Janicki JS, Weber KT: Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 69:107-115, 1991
241. Dayer J-M, Roelke MS, Krane SM: Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells. Biochem Pharmacol 33:2893-2899, 1984
242. Brilla CG, Matsubara L, Weber KT: Advanced hypertensive heart disease in spontaneously hypertensive rats: Lisinopril-mediated regression of myocardial fibrosis. Hypertension 28:269-275, 1996
243. Kaneto H, Morrissey J, McCracken R, et al: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45:1637-1647, 1994
244. Diamond JR, Anderson S: Irréversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Am J Pathol 137:1323-1332, 1990
245. Burdmann EA, Andoh TF, Nast CC, et al: Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 269:F491-499, 1995
246. Juncos LI, Carrasco Duefias S, Comejo JC, et al: Long-term enalapril and hydrochlorothiazide in radiation nephritis. Nephron 64:249-255, 1993
247. Tanaka R, Sugihara K, Tatematsu A, Fogo A: Intemephron heterogeneity of growth factors and sclerosismodulation of platelet-derived growth factor by angiotensin II. Kidney Int 47:131-139, 1995
248. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
249. Ikoma M, Kawamura T, Kakinuma Y, et al: Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 40:195-202, 1991
250. Shibouta Y, Chatani F, Ishimura Y, et al: TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats. Kidney Int 49:5115-118, 1996 (Suppl 55)
251. Tanaka R, Kon V, Yoshioka T, et al: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 45:537543,1994
252. Nakamura T, Obata J, Kuroyanagi R, et al: Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats. Kidney Int 49:5109-112, 1996 (Suppl 55)
253. Kim S, Ohta K, Hamaguchi A, et al: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 46:1346-1358, 1994
254. Komatsu K, Fröhlich ED, Ono H, et al: Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Effects of angiotensin-converting enzyme inhibition. Hypertension 25:207-213, 1995
255. Ward WF, Molteni A, Ts'ao C: Radiation-induced endothelial dysfunction and fibrosis in rat lung: Modification by the angiotensin converting enzyme inhibitor CL242817. Radiat Res 117:342-350, 1989
256. Ward WF, Molteni A, Ts'ao C-H, et al: Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 19:1405-1409, 1990
257. Ward WF, Molteni A, Ts'ao C, et al: Radiation pneumotoxicity in rats: Modification by inhibitors of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys 22:623625, 1992
258. Molteni A, Ward WF, Ts'ao C-H, et al: Monocrotaline-induced pulmonary fibrosis in rats: Amelioration by captopril and penicillamine (42151). Proc Soc Exp Biol Med 180:112-120, 1985
259. Zakheim RM, Mattioli L, Molteni A, et al: Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest 33:57-61, 1975
260. Morrell NW, Morris KG, Stenmark KR: Role of angiotensin-converting enzyme and angiotensin II in develop-ment of hypoxic pulmonary hypertension. Am J Physiol 269:H1168-1194, 1995
261. Weinstock JV, Ehrinpreis MN, Boros DL, Gee JB: Effect of SQ 14225, an inhibitor of angiotensin I-converting enzyme, on the granulomatous responses to Schistosoma mansoni eggs in mice. J Clin Invest 67:931-936, 1981
262. Ramos SG, Montenegro AP, Goissis G, Rossi MA: Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis. Pathol Int 44:655-661, 1994
263. Yoon S-C, Park J-M, Jang H-S, et al: Radioprotective effect of captopril on the mouse jenunal mucosa. Int J Radiat Oncol Biol Phys 30:873-878, 1994
264. Villarreal FJ, Kirn NN, Ungab GD, et al: Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88:2849-2861, 1993
265. Brilla CG, Zhou G, Matsubara L, Weber KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 26:809-820, 1994
266. Zhou G, Kandala JC, Tyagi SC, et al: Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 154:171-178, 1996
267. Tufro-McReddie A, Chevalier RL, Everett AD, Gomez RA: Decreased perfusion pressure modulates renin and ANG II type 1 receptor gene expression in the rat kidney. Am J Physiol 264:R696-702, 1993
268. Lopez JJ, Lorell BH, Ingelfinger JR, et al: Distribution and function of cardiac angiotensin ATi - and AT2 -receptor subtypes in hypertrophied rat hearts. Am J Physiol 267:H844-852, 1994
269. Doering CW, Jalil JE, Janicki JS, et al: Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 22:686-695, 1988
270. Jalil JE, Doering CW, Janicki JS, et al: Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64:1041-1050, 1989
271. Averill DB, Ferrario CM, Tarazi RC, et al: Cardiac performance in rats with renal hypertension. Circ Res 38:280-288, 1976
272. Chapman D, Weber KT, Eghbali M: Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res 67:787-794, 1990
273. Willems IEMG, Havenith MG, Smits JFM, Daemen MJAP: Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab Invest 71:127-133, 1994
274. Jalil JE, Janicki JS, Pick R, Weber KT: Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: Response to captopril. Am J Hypertens 4:51-55, 1991
275. Nicoletti A, Heudes D, Hinglais N, et al: Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone. Hypertension 26:101-111, 1995
276. Regan CP, Anderson PG, Bishop SP, Berecek KH: Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats. Am J Physiol 271:H906-913, 1996
277. Linz W, Schaper J, Wiemer G, et al: Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: A one year study in rats. Br J Pharmacol 107:970-975, 1992
278. Johnson CM, Hanson MM, Helgeson SC: Porcine cardiac valvular subendothelial cells in culture: Cell isolation and growth characteristics. J Mol Cell Cardiol 19:1185-1193, 1987
279. Crawford DC, Chobanian AV, Brecher P: Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 74:727-739, 1994
280. Kirn S, Ohta K, Hamaguchi A, et al: Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 25:1252-1259, 1995
281. Weber KT, Sun Y, Guarda E: Nonclassic actions of angiotensin II and aldosterone in nonclassic target tissue (the heart): Relevance to hypertensive heart disease, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, 2nd ed, vol 2. New York, NY, Raven Press, 1995, pp 2203-2223
282. Weber KT: Hormones and fibrosis: A case for lost reciprocal regulation. News Physiol Sei 9:123-128, 1994
283. Egido J: Vasoactive hormones and renal sclerosis. Kidney Int 49:578-597, 1996
284. Silverstein E, Friedland J, Vuletin JC: Marked elevation of serum angiotension-converting enzyme and hepatic fibrosis containing long-spacing collagen fibrils in type 2 acute neuronopathic Gaucher's disease. Am J Clin Pathol 69:467-471, 1978